| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |

From the Institute of Pathology,*
University of
Würzburg, Würzburg; and the Medizinische Klinik und
Poliklinik V,
University of Heidelberg,
Heidelberg, Germany
B-cell lymphomas of mucosa-associated lymphoid tissue (MALT) type
develop against a background of chronic inflammation and have
functional autoantigen receptors. Because they respond to environmental
factors in vivo, the expression of costimulatory
molecules, which play a key role in the differentiation of
normal B-lymphocytes and in T-/B-cell interaction, may be
critical in early MALT-type lymphoma pathogenesis until further
chromosomal aberration leads to progression. We found a high number of
tumor-infiltrating T-lymphocytes (TITLs) in all low-grade MALT-type
lymphomas. The TITLs in low-grade lymphomas were activated and
expressed a memory and immunocompetent phenotype. Reverse
transcriptase-polymerase chain reaction analyses and
immunohistochemistry confirmed the presence of CD40-ligand and
Fas-ligand in 80% of low-grade lymphomas. In contrast to the
TITLs, the tumor B cells did not express CD40-ligand or
Fas-ligand in vivo or in vitro.
Moreover, the cytokine profile in vivo suggested
a Th2/Th3-weighted profile (interleukin-10,
interleukin-13, transforming growth factor ß1)
rather than Th1-weighted (interferon-
, interleukin-2). By
interphase fluorescence in situ hybridization analysis
the translocation t(11;18)(q21;q21) was found in four of nine (44%)
cases studied. Interestingly, there was a four times higher
proliferation and survival rate of purified t(11;18)-positive tumor B
cells in vitro, although there were no
significant profile differences from the TITLs in vivo.
The finding of essential costimulating molecules in low-grade MALT-type
lymphomas in vivo indicates a locally directed cognate
T-/B-cell interaction. Consequently, a potentially equipped
inflammatory background may not only determine the fate of autoreactive
B-cells, but is also crucial to lymphoma maintenance and
progression.
This article has been cited by other articles:
![]() |
A. Mueller, J. O'Rourke, P. Chu, A. Chu, M. F. Dixon, D. M. Bouley, A. Lee, and S. Falkow The Role of Antigenic Drive and Tumor-Infiltrating Accessory Cells in the Pathogenesis of Helicobacter-Induced Mucosa-Associated Lymphoid Tissue Lymphoma Am. J. Pathol., September 1, 2005; 167(3): 797 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ho, R. E. Davis, B. Conne, R. Chappuis, M. Berczy, P. Mhawech, L. M. Staudt, and J. Schwaller MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-{kappa}B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells Blood, April 1, 2005; 105(7): 2891 - 2899. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Troen, V. Nygaard, T.-K. Jenssen, I. M. Ikonomou, A. Tierens, E. Matutes, A. Gruszka-Westwood, D. Catovsky, O. Myklebost, G. Lauritzsen, et al. Constitutive Expression of the AP-1 Transcription Factors c-jun, junD, junB, and c-fos and the Marginal Zone B-Cell Transcription Factor Notch2 in Splenic Marginal Zone Lymphoma J. Mol. Diagn., November 1, 2004; 6(4): 297 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yamasaki, K. Yokota, H. Okada, S. Hayashi, M. Mizuno, T. Yoshino, Y. Hirai, D. Saitou, T. Akagi, and K. Oguma Immune response in Helicobacter pylori-induced low-grade gastric-mucosa-associated lymphoid tissue (MALT) lymphoma J. Med. Microbiol., January 1, 2004; 53(1): 21 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hjelmström Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines J. Leukoc. Biol., March 1, 2001; 69(3): 331 - 339. [Abstract] [Full Text] |
||||
![]() |
E. Macintyre, D. Willerford, and S. W. Morris Non-Hodgkin's Lymphoma: Molecular Features of B Cell Lymphoma Hematology, January 1, 2000; 2000(1): 180 - 204. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |